Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,523 | 288 | 96.2% |
| Education | $294.25 | 4 | 3.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,682 | 74 | $0 (2024) |
| Janssen Biotech, Inc. | $932.29 | 39 | $0 (2024) |
| Amgen Inc. | $799.18 | 25 | $0 (2024) |
| Allergan, Inc. | $643.53 | 9 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $608.20 | 23 | $0 (2024) |
| Lilly USA, LLC | $422.22 | 17 | $0 (2024) |
| GENZYME CORPORATION | $329.60 | 13 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $287.47 | 14 | $0 (2024) |
| Incyte Corporation | $254.87 | 7 | $0 (2024) |
| Galderma Laboratories, L.P. | $250.37 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,636 | 97 | ABBVIE INC. ($775.64) |
| 2023 | $1,313 | 59 | ABBVIE INC. ($286.79) |
| 2022 | $981.41 | 44 | ABBVIE INC. ($306.42) |
| 2021 | $145.29 | 6 | AbbVie Inc. ($52.18) |
| 2020 | $354.43 | 10 | Janssen Biotech, Inc. ($143.89) |
| 2019 | $1,742 | 50 | Allergan Inc. ($378.61) |
| 2018 | $614.25 | 24 | Janssen Biotech, Inc. ($201.98) |
| 2017 | $31.35 | 2 | PFIZER INC. ($18.85) |
All Payment Transactions
292 individual payment records from CMS Open Payments — Page 2 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/01/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $16.44 | General |
| 09/27/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $32.06 | General |
| Category: DERMATOLOGY | ||||||
| 09/27/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $24.68 | General |
| Category: IMMUNOLOGY | ||||||
| 09/26/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | Cabtreo (Drug) | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: Dermatology | ||||||
| 09/24/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: DERMATOLOGY | ||||||
| 09/23/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $10.52 | General |
| Category: Inflammation | ||||||
| 09/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $31.91 | General |
| Category: IMMUNOLOGY | ||||||
| 09/17/2024 | Lilly USA, LLC | TALTZ (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: Immunology | ||||||
| 09/16/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $14.88 | General |
| 09/13/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $41.38 | General |
| Category: Immunology | ||||||
| 09/10/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: DERMATOLOGY | ||||||
| 08/30/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $29.72 | General |
| 08/30/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $24.76 | General |
| Category: Dermatology | ||||||
| 08/28/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $2.86 | General |
| Category: Dermatology | ||||||
| 08/27/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: DERMATOLOGY | ||||||
| 08/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $30.13 | General |
| Category: IMMUNOLOGY | ||||||
| 08/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $26.39 | General |
| Category: Immunology | ||||||
| 08/13/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $35.96 | General |
| Category: Immunology | ||||||
| 08/06/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $27.67 | General |
| Category: Dermatology | ||||||
| 08/02/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $6.57 | General |
| Category: Inflammation | ||||||
| 08/01/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $33.97 | General |
| Category: IMMUNOLOGY | ||||||
| 07/23/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: DERMATOLOGY | ||||||
| 07/22/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $42.26 | General |
| Category: Immunology | ||||||
| 07/15/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $27.78 | General |
| Category: DERMATOLOGY | ||||||
| 07/12/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $26.53 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,418 | 2,730 | $665,632 | $149,651 |
| 2022 | 12 | 747 | 1,312 | $267,611 | $62,836 |
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 186 | 268 | $103,716 | $25,372 | 24.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 221 | 302 | $77,010 | $20,499 | 26.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 117 | 183 | $68,625 | $18,240 | 26.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 142 | 183 | $63,135 | $12,083 | 19.1% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 51 | 72 | $38,088 | $10,217 | 26.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 197 | 260 | $59,540 | $9,596 | 16.1% |
| 13101 | Complicated repair of wound of trunk, 2.6-7.5 cm | Office | 2023 | 23 | 26 | $36,478 | $9,030 | 24.8% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 17 | 20 | $30,240 | $7,433 | 24.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 160 | 1,033 | $23,759 | $6,198 | 26.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 64 | 64 | $23,808 | $4,853 | 20.4% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 17 | 18 | $19,170 | $4,764 | 24.9% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 36 | 42 | $36,540 | $4,611 | 12.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 43 | 43 | $24,381 | $4,416 | 18.1% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 59 | 89 | $16,376 | $3,879 | 23.7% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 18 | 28 | $12,824 | $3,226 | 25.2% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 17 | 20 | $19,880 | $2,363 | 11.9% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 11 | 11 | $4,785 | $1,262 | 26.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 17 | 19 | $3,002 | $891.90 | 29.7% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 11 | 20 | $3,840 | $693.32 | 18.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 11 | 29 | $435.00 | $23.73 | 5.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 98 | 124 | $47,988 | $11,733 | 24.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 107 | 130 | $33,150 | $9,621 | 29.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 45 | 70 | $26,250 | $7,507 | 28.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 88 | 96 | $33,120 | $6,843 | 20.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 115 | 144 | $32,976 | $5,670 | 17.2% |
About Karyn Haitz
Karyn Haitz is a Internal Medicine healthcare provider based in Los Alamitos, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/18/2017. The National Provider Identifier (NPI) number assigned to this provider is 1962932384.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Karyn Haitz has received a total of $7,817 in payments from pharmaceutical and medical device companies, with $2,636 received in 2024. These payments were reported across 292 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($7,523).
As a Medicare-enrolled provider, Haitz has provided services to 2,165 Medicare beneficiaries, totaling 4,042 services with total Medicare billing of $212,487. Data is available for 2 years (2022–2023), covering 32 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Dermatology
- Location Los Alamitos, CA
- Active Since 06/18/2017
- Last Updated 08/19/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1962932384
Products in Payments
- SKYRIZI (Biological) $892.84
- Otezla (Drug) $800.52
- COSENTYX (Biological) $525.10
- DUPIXENT (Biological) $509.89
- Tremfya (Drug) $455.53
- TREMFYA (Drug) $441.26
- TALTZ (Drug) $422.22
- BOTOX COSMETIC (Biological) $296.47
- OPZELURA (Drug) $254.87
- Erivedge (Biological) $226.78
- RINVOQ (Biological) $225.23
- ADBRY (Biological) $181.28
- Humira (Biological) $161.01
- VTAMA (Drug) $146.79
- Klisyri (Drug) $138.65
- ILUMYA (Biological) $122.03
- EUCRISA (Drug) $119.53
- SPEVIGO (Drug) $102.94
- Sotyktu (Drug) $71.59
- HUMIRA (Biological) $60.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Los Alamitos
Dr. Rebekah Neal-Kraal, M.d, M.D
Internal Medicine — Payments: $42,492
Etsegenet Ayele, M.d, M.D
Internal Medicine — Payments: $18,183
Dr. Steven Becker, D.o, D.O
Internal Medicine — Payments: $11,752
Robert Lee, M.d, M.D
Internal Medicine — Payments: $9,928
Harold Lin, M.d, M.D
Internal Medicine — Payments: $8,765
Jack Rubin, M.d, M.D
Internal Medicine — Payments: $7,388